Use of peptide receptor agonists and antagonists for diagnosis and treatment

Digestion

Volumn 58, Issue , 1997, Pages 86-93

  Jensen, Robert T ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Agonist; Antagonist; Bradykinin; Cholecystokinin; Endothelin; Gastrin releasing peptide; Octreotide; Peptide receptors

Indexed keywords

BRADYKININ; CHOLECYSTOKININ; ENDOTHELIN; GASTRIN RELEASING PEPTIDE; GASTROINTESTINAL POLYPEPTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; HYPOTHALAMUS RELEASE INHIBITING FACTOR; OCTREOTIDE; PEPTIDE RECEPTOR AGONIST; PEPTIDE RECEPTOR ANTAGONIST; RECEPTOR; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

CONFERENCE PAPER; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR BINDING;

ANIMALS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL HORMONES; HORMONE ANTAGONISTS; HUMANS; RECEPTORS, PEPTIDE;

EID: 0030976112     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000201536     Document Type: Article

References (26)

1. Walsh JH, Dockrav GJ: Gut Peptides. Comprehensive Endocrinology. New York. Raven Press. 1994. pp. 1-884.
2. Jenson RT: Peptide therapy. Recent advances in the use of somatostatin and other peptide receptor agonists and antagonists: in Lewis J. Duboisi A (eds): Current Clinical Topics in Gastrointestinal Pharmacology. Malden. Blackwell Science. 1997. pp 144-223.
3. Jensen RT, Coy DH: Peptide receptor agonists/antagonists: Discovery, present and possible future clinical uses, in Övvyang C (ed): Diagnostic and Therapeutic Uses of Peptide Receptor Agonists and Antagonists. Regulatory Peptide Letter. Ann Arbor. MED 1994. vol 5. pp45-51.
4. Logsdon CD: Molecular structure and function of G-protein-linked receptors: in Johnson LR (ed): Physiology of the Gastrointestinal Tract. New York. Raven Press. 1994. Vol 3. pp 351-380.
5. Schwartz TW: Locating ligand-binding sites in 7TM receptors by protein engineering. Curr Opin Biotechnol 1994:5:434-444.
6. Schwartz TW, Rosenkilde M: Is there a 'lock' for all agonist 'keys' in 7TM receptors? Trends Pharmacol Sei 1996:17:205-234.
7. Lamberts SWJ, van der Lely AJ, de Herder W, Holland LJ: Octreotide. N Engl J Med 1996: 334:246-254.
8. Reisine T: Somatostatin receptors. Am J Physiol 1995:269:G813-G820.
9. Gibril E, Reynolds JC, Doppman JL, Chen C, Venzon DJ, Termanini B, Weber HC, Stewart CA, Jensen RT: Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in delecting primary and metastatic gastriinomas. A prospective study. Ann Intern Med 1996:125:26-34.
10. 3]-octreotide: The Rotterdam experience with more than 1.000 patients. Eur J Nucl Med 1993:20: 716-731.
11. Peeters TL: Erythromycin and other macrolidcs as prokinetic agents. Gastroenterology 1993: 105:1886-1891.
12. Meyer BM, Werth BA, Beglinger C, Hildebrand P, Jansen JB, Zach D, Rovati EC, Slalder GA: Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 1989:ii:12-15.
13. Meyer-Wyss B, Werth B, Belinger C: Regulation of gastrointestinal and colonic transit by CCK antagonists: in Adler G. Beglmger C (eds): Cholecystokinin Antagonists in Gastroenterology. Berlin. Springer. 1991. pp 183-193.
14. Harro J, Vasar E, Bradvvejn J: CCK in animal and human research on anxiety. Trends Pharmacol Sci 1993:14:244-249.
15. Jensen RT: CCKB gastrin receptor antagonists. Recent advances and potential uses in gastric secretory disorders. Yale J Biol Med 1997: in press.
16. Calam J: CCK/Gastrin anlagonlsts-clinical perspectives. Acta Gastroenterol Belg 1993:56:251-256.
17. Anonymous: Receptor and ion channel nomenclature supplement. Trends Pharmacol Sci 1996: 7:1-81.
18. Joos GF, Germonpre PR, Kips JC, Pelentan RA, Pauvvcls RA: Sensory neuropeptides and the human lower airways: Present state and future directions. Eur Respir J 1994:7:1161-1171.
19. Jensen RT, Norton JA: Carcinoid tumors and the carcinoid syndrome: in Cancer: Principles and Practice of Oncology. Philadelphia. Lippincolt-Raven. 1997. pp 1704-1723.
20. Lerelt M, Wcidenbaeh H, Gross TM, Adler G: Effect of kinin inhibition in experimental acute pancreatitis. Am J Physiol 1995:269:G490-G499.
21. Levin ER: Endothclins. N Engl J Med 1995: 333:356-363.
22. Luscher TE, Wenzel R: Endothelin and endo-thclin antagonists Pharmacology and clinical implications. Agents Actions 1995:45(suppl): 237-253.
23. Barone EC, Willetle RN, Yue TL, Ieureslein G: Therapeutic effects of endothelin receptor antagonists in stroke. Neurol Res 1995:17:259-264.
24. Tamirisa P, Frishman WEI, Kumar A: Endothelin and endothelin antagonism: Roles in cardiovascular health and disease. Am Heart J 1995:130:601-610.
25. Webb DJ, Haynes WG: Endothclins come of age. Lancet 1993:342:1439-1440
26. Barnes PJ: Endothclins and pulmonary diseases. J Appl Physiol 1994:77:1051-1059.